Circulating Tumor Cells (CTC) in Cancer

Recruiting now

Conditions studied: Cancer

In brief

This observational study with circulating tumor cells (CTC) count, isolation and analysis at several time points during disease progression is to investigate the role and biology of CTCs and clusters of CTCs in different cancer types. It also evaluates the role of CTCs as biomarkers, and aims at the identification of key signaling networks that are active in CTCs.

Key facts

Study ID

NCT04520672

Run by

University Hospital, Basel, Switzerland

People needed

3000

Starts

2020-10-01

Expected to finish

2030-08-01

Last updated by the study team

2025-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult cancer patients
• All patients with histology-based proved diagnosis of cancer, all stages and subtypes can be included. Precancerous lesions cannot be included.
• All patients with the diagnosis of a solid tumor including adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma, sarcoma
• Written pathology report must be available.
• Written informed consent.

You may not qualify if…

• No written informed consent.
• No proved diagnosis of malignancy by pathology report.
• Patients with the diagnosis of blood cancer

Where it is running

• University Hospital Basel — Basel, Switzerland (enrolling)
• Department Oncology, Haematology & Immuntherapy, Kantonsspital Baselland — Liestal, Switzerland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.